Cardinal Health said on Tuesday its unit would buy Solaris Health and the company would provide about $1.9 billion in cash ...

Cardinal Health (NYSE: CAH) today announced that The Specialty Alliance, its multi-specialty management services organization ...

Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.

Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday ...

Analysts expect the health care company to report quarterly earnings at $2.03 per share, up from $1.84 per share in the ...

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug ...

U.S. stock futures are down, with earnings from Cardinal Health Inc. and Sea Ltd. to watch. ZipRecruiter Inc. beats ...

Approximately six in 10 U.S. adults reported taking a prescription drug, and a quarter of U.S. adults take four or more.

Wall Street analysts forecast that Cardinal Health (CAH) will report quarterly earnings of $2.03 per share in its upcoming release, pointing to a year-over-year increase of 10.3%. It is anticipated ...

Headquartered in Columbus, Ohio, Cardinal Health is a global, integrated healthcare services and products company that generated $205 billion in revenue in its fiscal year 2023. The company plays ...

Cardinal Health Inc. is exploring a potential sale of its nuclear medicine business as part of a larger review of its strategy and operations, according to people familiar with the matter.

Drug distributor Cardinal Health said on Tuesday it would acquire Solaris Health for about $1.9 billion in cash.